BI
Biogaia
SEMid Cap
Latest price
108.10 SEK
17/09/2026
Latest (1)
140.00 SEK
+29.51%
Upside
AVG (2)
137.50 SEK
+27.20%
Upside
Aligned
BIOG-B
3 mo+27.20%2 price targets
6 mo+29.51%5 price targets
1 yr+29.51%5 price targets
Max 5 price targets
HealthcareDrug Manufacturers—Specialty & Generic
Overview
Analysts
About The Company
Biogaia AB is a Swedish biotechnology company that develops and sells probiotic products. Biogaia has been developed from research findings on the lactic acid bacterium Limosilactobacillus reuteri and the substance reuterin, which was carried out by Walter Dobrogosz and Sven Lindgren in the 1980s.
Wikipedia
Latest Target
The most recently set price target for the stock, from a single analyst.
Target
140.00 SEK
Upside
+29.51%
Latest price108.10 SEK
Three Month Consensus
The median of each house's latest target set within the last 90 days.
Consensus
137.50 SEK
Upside
+27.20%
Aligned2 houses · range 135.00 SEK–140.00 SEK · last 90 days
135.00 SEK140.00 SEK
line = latest price · dot = consensus
Latest price108.10 SEK
Insider Trades for Biogaia
No insider trades for the selected period.
